Drug Regulatory Affairs (DRA) – Pharmaguideline Courses

About Course

This comprehensive course on Drug Regulatory Affairs is designed to provide a complete understanding of the global regulatory frameworks that govern the pharmaceutical industry. It is ideal for students, industry professionals, and aspiring regulatory specialists who want to learn how drugs are developed, approved, and monitored for safety and effectiveness.

Introduction to Regulatory Affairs: Understand the role of regulatory professionals in drug development and compliance.
Drug Development Process: Learn all stages from discovery to post-marketing and how regulations apply at each stage.
Major Global Regulatory Authorities: Explore roles of FDA, EMA, PMDA, MHRA, TGA, CDSCO, Health Canada, and NMPA.
Regulatory Submission Types: Understand NDA, ANDA, BLA, IND, MAA, and other global submission formats.
Common Technical Document (CTD/eCTD): Learn how to structure and prepare regulatory dossiers for global agencies.
Clinical Trials Oversight: Understand trial phases, protocols, informed consent, and GCP principles
Labeling and Advertising Regulations: Learn about compliant drug labeling, packaging, and promotional material.
Post-Marketing Surveillance & Pharmacovigilance: Monitor drug safety and manage adverse event reporting after approval.
Inspections and Compliance: Prepare for FDA, EMA, and other audits with best practices and documentation.
Regulatory Affairs for Biologics & Medical Devices: Special regulatory considerations for vaccines, biotech products, and devices.
Emerging Trends & Harmonization: Keep up with global harmonization, AI in regulatory affairs, and digital health regulations.

Course Content

Introduction

Introduction to the Course

00:00

Module 1: Introduction to Regulatory Affairs

Module 2: Drug Development Process & Regulatory Interfaces

Module 3: Regulatory Authorities Around the World

Section 1: What Are Drug Regulatory Authorities?

01:41
Section 2: United States – Food and Drug Administration (FDA)

01:49
Section 3: European Union – European Medicines Agency (EMA)

01:51
Section 4: United Kingdom – MHRA

01:41
Section 5: Japan – PMDA and MHLW

01:45
Section 6: Canada – Health Canada

01:48
Section 7: Australia – TGA

01:43
Section 8: China – NMPA

01:44
Section 9: Other Key Authorities

02:26
Section 10: Harmonization and Work-Sharing

02:23

Module 4: Regulatory Submissions and Approvals

Module 5: Clinical Trials and Regulatory Oversight

Module 6: Labeling, Packaging, and Advertising Regulations

Module 7: Post-Marketing Surveillance and Pharmacovigilance

Module 8: Regulatory Compliance and Inspections

Module 9: Regulatory Affairs for Biologics, Vaccines & Medical Devices

Module 10: Emerging Trends & Future of Regulatory Affairs

Summery

Certificate

Add this certificate to your resume to demonstrate your skills & increase your chances of getting noticed.

About Course

What Will You Learn?

Course Content

Introduction

Introduction to the Course

Module 1: Introduction to Regulatory Affairs

Section 1: Overview of Regulatory Affairs

Section 2: Key Roles in Regulatory Affairs

Section 3: The Regulatory Environment

Section 4: The Regulatory Process

Section 5: Conclusion

Module 2: Drug Development Process & Regulatory Interfaces

Section 1: Overview of the Drug Development Lifecycle

Section 2: Detailed Phases of Drug Development

Section 3: Regulatory Interfaces During Development

Section 4: Chemistry, Manufacturing & Controls (CMC) and Quality Interface

Section 5: Nonclinical and Clinical Regulatory Documentation

Section 6: Regulatory Submissions – Global Considerations

Section 7: Summary

Module 3: Regulatory Authorities Around the World

Section 1: What Are Drug Regulatory Authorities?

Section 2: United States – Food and Drug Administration (FDA)

Section 3: European Union – European Medicines Agency (EMA)

Section 4: United Kingdom – MHRA

Section 5: Japan – PMDA and MHLW

Section 6: Canada – Health Canada

Section 7: Australia – TGA

Section 8: China – NMPA

Section 9: Other Key Authorities

Section 10: Harmonization and Work-Sharing

Module 4: Regulatory Submissions and Approvals

Section 1: The Regulatory Submission Process Overview

Section 2: Submission Types

Section 3: The Common Technical Document (CTD)

Section 4: Electronic Submissions (eCTD)

Section 5: Preparing a Regulatory Submission

Section 6: Regulatory Review Process

Section 7: Post-Approval Changes and Variations

Module 5: Clinical Trials and Regulatory Oversight

Section 1: Overview of Clinical Trials

Section 2: Regulatory Oversight of Clinical Trials

Section 3: Clinical Trial Protocol

Section 4: Informed Consent

Section 5: Good Clinical Practice (GCP)

Section 6: Regulatory Requirements in Clinical Trials

Section 7: Common Challenges and Solutions

Module 6: Labeling, Packaging, and Advertising Regulations

Section 1: Importance of Labeling, Packaging, and Advertising in Pharma

Section 2: Regulatory Requirements for Labeling

Section 3: Regulatory Requirements for Packaging

Section 4: Advertising Regulations for Pharmaceutical Products

Section 5: Case Studies and Common Issues

Module 7: Post-Marketing Surveillance and Pharmacovigilance

Section 1: Introduction to Post-Marketing Surveillance

Section 2: Key Activities in Post-Marketing Surveillance

Section 3: Global Pharmacovigilance Systems

Section 4: Detecting and Managing Safety Signals

Module 8: Regulatory Compliance and Inspections

Section 1: Introduction to Regulatory Compliance

Section 2: Types of Regulatory Inspections

Section 3: Inspection Procedures

Section 4: Consequences of Non-Compliance

Module 9: Regulatory Affairs for Biologics, Vaccines & Medical Devices

Section 1: Introduction to Biologics, Vaccines, and Medical Devices

Section 2: Regulatory Framework for Biologics

Section 3: Regulatory Affairs for Vaccines

Section 4: Regulatory Affairs for Medical Devices

Section 5: Key Differences Between Biologics, Vaccines, and Medical Devices

Module 10: Emerging Trends & Future of Regulatory Affairs

Section 1: Technological Advancements in Regulatory Affairs

Section 2: Globalization of Regulatory Affairs

Section 3: Personalized Medicine and Its Regulatory Challenges

Section 4: Regulatory Affairs and Sustainability

Section 5: Future Regulatory Trends

Summery

Summery of Course

Certificate

Questions to Answer

Earn a certificate

About Ankur Choudhary